STERIS
STE • NYSE
STERIS is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Daniel A. Carestio, with a market cap of $22.6B.
CEODaniel A. Carestio
Market Cap$22.6B
Medical - Devices
Healthcare
Employees18.2K
Websitesteris.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for STERIS
Date
Wednesday, May 13, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2026
EPS Estimate
$2.86
Revenue Estimate
$1.6B
Earnings History
Past 12 earnings reports for STERIS
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q3 2026 | $2.53Est: $2.53 | 0.0% | $1.5BEst: $1.5B | +1.3% |  10-Q |
| Nov 5, 2025 | Q2 2026 | $2.47Est: $2.36 | +4.7% | $1.5BEst: $1.4B | +2.0% | 10-Q |
| Aug 6, 2025 | Q1 2026 | $2.34Est: $2.29 | +2.2% | $1.4BEst: $1.4B | +2.2% | 10-Q |
| May 14, 2025 | Q4 2025 | $2.74Est: $2.60 | +5.4% | $1.5BEst: $1.5B | +0.7% | 10-K |
| Feb 5, 2025 | Q3 2025 | $2.32Est: $2.32 | 0.0% | $1.4BEst: $1.4B | -0.7% | 10-Q |
| Nov 6, 2024 | Q2 2025 | $2.14Est: $2.12 | +0.9% | $1.3BEst: $1.3B | -0.1% | 10-Q |
| Aug 6, 2024 | Q1 2025 | $2.03Est: $1.98 | +2.5% | $1.3BEst: $1.3B | +0.6% | 10-Q |
| May 8, 2024 | Q4 2024 | $2.58Est: $2.38 | +8.4% | $1.4BEst: $1.4B | -0.8% | 10-K |
| Feb 7, 2024 | Q3 2024 | $2.22Est: $2.17 | +2.3% | $1.4BEst: $1.4B | +3.4% | 10-Q |
| Nov 7, 2023 | Q2 2024 | $2.03Est: $2.01 | +1.0% | $1.3BEst: $1.3B | +3.2% | — |
| Aug 1, 2023 | Q1 2024 | $2.00Est: $1.86 | +7.5% | $1.3BEst: $1.2B | +7.8% | 10-Q |
| May 10, 2023 | Q4 2023 | $2.30Est: $2.15 | +7.0% | $1.4BEst: $1.3B | +9.1% | — |